Faculty profile
Robert Zamboni
Back to facultyResearch
Read how they describe their research on their McGill University profile.
Latest papers
Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns
Journal of Leukocyte Biology · 2017
Latest funding
- $1,600,000
Novel First-In-Class Melatonin MT2 Receptor Agonist for Neuropathic Pain: Investigational New Drug (IND) – Enabling Studies
BRAIN · 2019 · Co-investigator
- $927,945
Pharmacological chaperones that bind F508del-CFTR and their mechanisms of action
CIHR · 2017 · Co-investigator
1 publications.
Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns
Adam G. Peres, Robert J. Zamboni, Irah L. King, Joaquı́n Madrenas
Novel First-In-Class Melatonin MT2 Receptor Agonist for Neuropathic Pain: Investigational New Drug (IND) – Enabling Studies
Principal investigators: Gobbi, Gabriella
Keywords: Central Nervous System; Other
Pharmacological chaperones that bind F508del-CFTR and their mechanisms of action
Principal investigators: Hanrahan, John W
Keywords: Cystic Fibrosis; Er Chaperones; Er Regulation; Human Primary Bronchial Epithelial Cells; Mechanisms Of Action; Medicinal Compound Synergy; Pharmacological Chaperones; Protein Trafficking Disease; Protein-Protein Interactions; Sites Of Action
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.